IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.275
-0.026 (-8.74%)
At close: Oct 29, 2024, 4:00 PM
0.280
+0.005 (1.97%)
After-hours: Oct 29, 2024, 7:57 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $12.85 million as of October 29, 2024. Its market cap has decreased by -56.45% in one year.
Market Cap
12.85M
Enterprise Value
9.76M
1-Year Change
-56.45%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $12.85M, a decrease of -93.15%. That is a compound annual growth rate of -56.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 14.10M | -68.03% |
| Dec 29, 2023 | 44.10M | -22.08% |
| Dec 30, 2022 | 56.60M | -31.23% |
| Dec 31, 2021 | 82.30M | -56.12% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 14.99M |
| Apollomics | 14.98M |
| Cara Therapeutics | 14.70M |
| Nephros | 14.55M |
| China Jo-Jo Drugstores | 14.54M |
| NKGen Biotech | 14.38M |
| Biora Therapeutics | 14.34M |
| Evogene | 14.16M |